Incannex Healthcare Limited - ADR

The momentum for this stock is not very good. Incannex Healthcare Limited - ADR is not a good value stock. Incannex Healthcare Limited - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Incannex Healthcare Limited - ADR.
Log in to see more information.
IXHL Fundamental Data by TradingView

News

Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies

Benzinga Incannex Healthcare secures $60M in financing from Arena Investors to support clinical trials for cannabinoid and psychedelic therapies.\n more…

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors
Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors

Globe Newswire Incannex to Receive Funding of Up to $10 Million in Convertible Notes and $50 Million Equity Line of CreditNEW YORK and MELBOURNE, Australia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare...\n more…

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives
Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Newsfile Corp. - News Releases A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients...\n more…

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update

Ticker Report Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 65,800 shares, an...\n more…

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 177.9% in July
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 177.9% in July

Ticker Report Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totalling 38,900 shares, an...\n more…

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed
FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Globe Newswire Approval from FDA to proceed with 94 patient Phase 2 clinical trial received following review of IND dossier containing information on the clinical trial, as well as safety and quality of the...\n more…